Development of sales channels and expansion of transactions with sales companies serving foreign customers in the Healthcare business

「The company has also achieved results, including adoption by major companies after promoting the benefits and efficacy of silent estrogen, and will continue actively approaching major companies while working to raise awareness of silent estrogen.」

「The company has also achieved results, including adoption by major companies after promoting the benefits and efficacy of silent estrogen, and will continue actively approaching major companies while working to raise awareness of silent estrogen.」

「Sales of products related to “IT maitake” produced by the company and possessing silent estrogen activity, including “EstroRich,” a supplement sold exclusively by 株式会社大木, a major pharmaceutical wholesaler, as well as OEM services and raw-material sales, remained firm. Revenue reached ¥293 million, or 114.0% of the previous fiscal year's level.」

「Sales of products related to “IT maitake” produced by the company and possessing silent estrogen activity, including “EstroRich,” a supplement sold exclusively by 株式会社大木, a major pharmaceutical wholesaler, as well as OEM services and raw-material sales, remained firm. Third-quarter revenue reached ¥223 million, or 114.6% of the year-earlier level.」

「Sales of products related to “IT maitake” produced by the company and possessing silent estrogen activity, including “EstroRich,” a supplement sold exclusively by 株式会社大木, a major pharmaceutical wholesaler, as well as OEM services and raw-material sales, remained firm. Second-quarter revenue reached ¥147 million, or 114.9% of the year-earlier level.」

「Sales of “EstroRich,” a supplement containing “IT maitake” produced by the company as an exclusive product of 株式会社大木, a major pharmaceutical wholesaler, were strong. Supplement sales to foreign customers also contributed, and first-quarter revenue reached ¥81 million, or 114.2% of the year-earlier level.」

「The company actively sold products, mainly the new product “IT Maitake Furikake,” launched in January 2018, at department stores and other outlets, distributing them through channels that make them more accessible to general consumers. It also began launching “EstroRich,” a supplement containing “IT maitake,” as an exclusive product of 株式会社大木, a major pharmaceutical wholesaler. As a result, maitake products accounted for an increasing share of Healthcare business revenue.」

「The company also began launching “EstroRich,” a supplement containing IT maitake, as an exclusive product of 株式会社大木, a major pharmaceutical wholesaler. As a result, maitake products accounted for an increasing share of Healthcare business revenue.」

「OEM projects with major companies have also progressed to the product-development stage, and we will continue steadily implementing initiatives to raise awareness and expand sales channels.」

「From the second quarter onward, business discussions with major department stores also progressed. We will expand sales by distributing maitake products through channels that make them more accessible to general consumers and through various initiatives, including OEM supply to major companies.」

「The company focused on selling maitake products and achieved a certain level of success in expanding sales channels, including having its products adopted for a specialized cosmetics and beauty area operated by Laox Co., Ltd. Revenue reached ¥272 million, or 113.4% of the previous fiscal year's level.」

「During the third quarter, our cosmetics were adopted for Laox Co., Ltd.'s Japan Cosmetics Lounge, a specialized cosmetics and beauty area, strengthening sales targeting inbound customers. As a result of focusing on expanding sales of maitake products, revenue reached ¥207 million, or 129.0% of the year-earlier level.」

「The company mainly sells maitake products. As a result of measures including strengthening sales targeting inbound customers during the second quarter, revenue increased by more than 30% year on year to ¥141 million.」

「We continued to develop sales channels and achieved results during the fiscal year, including expanding transactions with several sales companies serving foreign customers. We also received a certain level of recognition for the benefits and efficacy of maitake products, and from the fourth quarter began selling maitake raw materials and offering OEM services. These initiatives helped secure new revenue sources and raise awareness of maitake products. As a result, revenue was 30% higher than in the previous fiscal year, contributing to improved performance.」

「We continued to develop sales channels and achieved results during the third quarter, including expanding transactions with several sales companies serving foreign customers.」